muscimol has been researched along with Sarcoma 180 in 1 studies
Muscimol: A neurotoxic isoxazole isolated from species of AMANITA. It is obtained by decarboxylation of IBOTENIC ACID. Muscimol is a potent agonist of GABA-A RECEPTORS and is used mainly as an experimental tool in animal and tissue studies.
muscimol : A member of the class of isoxazoles that is 1,2-oxazol-3(2H)-one substituted by an aminomethyl group at position 5. It has been isolated from mushrooms of the genus Amanita.
Sarcoma 180: An experimental sarcoma of mice.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study evaluated the carvacrol (CARV) effect on hyperalgesia and nociception induced by sarcoma 180 (S180) in mice." | 7.80 | Evidence for the involvement of descending pain-inhibitory mechanisms in the attenuation of cancer pain by carvacrol aided through a docking study. ( Alves, RS; Bezerra, DP; De Lucca Júnior, W; Gelain, DP; Guimarães, AG; Melo, NS; Mendonça Júnior, FJ; Quintans Júnior, LJ; Scotti, L; Scotti, MT, 2014) |
| "The present study evaluated the carvacrol (CARV) effect on hyperalgesia and nociception induced by sarcoma 180 (S180) in mice." | 3.80 | Evidence for the involvement of descending pain-inhibitory mechanisms in the attenuation of cancer pain by carvacrol aided through a docking study. ( Alves, RS; Bezerra, DP; De Lucca Júnior, W; Gelain, DP; Guimarães, AG; Melo, NS; Mendonça Júnior, FJ; Quintans Júnior, LJ; Scotti, L; Scotti, MT, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guimarães, AG | 1 |
| Scotti, L | 1 |
| Scotti, MT | 1 |
| Mendonça Júnior, FJ | 1 |
| Melo, NS | 1 |
| Alves, RS | 1 |
| De Lucca Júnior, W | 1 |
| Bezerra, DP | 1 |
| Gelain, DP | 1 |
| Quintans Júnior, LJ | 1 |
1 other study available for muscimol and Sarcoma 180
| Article | Year |
|---|---|
Evidence for the involvement of descending pain-inhibitory mechanisms in the attenuation of cancer pain by carvacrol aided through a docking study.
Topics: Analgesics; Animals; Cymenes; Dose-Response Relationship, Drug; Hyperalgesia; Interleukin-10; Male; | 2014 |